Ipca Laboratories (NSE:IPCALAB) Tariff Resilience Score: 0/10 (As of Jul. 06, 2026)


NSE:IPCALAB Ipca Laboratories Ltd NSE:IPCALAB
92 GF Score
Price ₹1,778.90
GF Value ₹1,599.88
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Ipca Laboratories Tariff Resilience Score?

Ipca Laboratories has the Tariff Resilience Score of 0, which implies that the company might have .

Ipca Laboratories has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Ipca Laboratories might have .

Ipca Laboratories  (NSE:IPCALAB) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Ipca Laboratories Tariff Resilience Score Related Terms

NSE:IPCALAB
92GF Score
Ipca Laboratories Ltd NSE:IPCALAB
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ipca Laboratories (NSE:IPCALAB) Overvalued in 2026?

Based on GuruFocus' analysis, Ipca Laboratories stock appears to be overvalued. The current stock price of ₹1,778.90 is trading 11.2% above its estimated GF Value™ of ₹1,599.88. GuruFocus considers Ipca Laboratories to be Modestly Overvalued.

Key valuation signals for NSE:IPCALAB:

  • Tariff Resilience Score: 0
  • GF Value™: ₹1,599.88 vs. price of ₹1,778.90 (11.2% above fair value)
  • GF Score™: 92/100 with 5 warning signs

No single metric tells the full story. See the NSE:IPCALAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ipca Laboratories Business Description

Other Exchanges 524494:India
Address No. 48, 123 AB, 125 & 126 Kandivli Industrial Estate, Kandivli (West), Mumbai, MH, IND, 400067
Ipca Laboratories Ltd is a pharmaceutical company. The company's principal activity is the Development, Manufacturing, and Marketing of Pharmaceuticals Products. The company's API products include Atenolol (anti-hypertensive), Chloroquine Phosphate (anti-malarial), Chlorthalidone (diuretic), Furosemide (diuretic), Hydroxychloroquine Sulphate (DMARD), Losartan. The company has only one reportable primary business segment, pharmaceuticals.
92GF Score

Get the complete analysis for NSE:IPCALAB

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,778.90
Price
₹1,599.88
GF Value